This study clarifies the nonclassical mechanism of Wee1 regulation of SCLC therapeutic resistance, which provides a theoretical basis for the clinical understanding of the regulatory network of Wee1 and its use as a target for overcoming therapeutic resistance. Here, WEE1 is linked to small cell lung carcinoma.